MA41826B1 - Anti-icos antibodies - Google Patents

Anti-icos antibodies

Info

Publication number
MA41826B1
MA41826B1 MA41826A MA41826A MA41826B1 MA 41826 B1 MA41826 B1 MA 41826B1 MA 41826 A MA41826 A MA 41826A MA 41826 A MA41826 A MA 41826A MA 41826 B1 MA41826 B1 MA 41826B1
Authority
MA
Morocco
Prior art keywords
antibodies
icos antibodies
icos
bind
cancer
Prior art date
Application number
MA41826A
Other languages
French (fr)
Inventor
Stephen Sazinsky
Jennifer S Michaelson
Sriram Sathyanarayanan
Kutlu Goksu Elpek
Original Assignee
Jounce Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jounce Therapeutics Inc filed Critical Jounce Therapeutics Inc
Priority claimed from PCT/US2016/023524 external-priority patent/WO2016154177A2/en
Publication of MA41826B1 publication Critical patent/MA41826B1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne divers modes de réalisation se rapportant à des anticorps. Certains des modes de réalisation concernent des anticorps agonistes qui se lient à icos. Ces anticorps peuvent être utilisés dans des méthodes pour traiter, par exemple, le cancer.Various embodiments relating to antibodies are provided. Some of the embodiments relate to agonist antibodies that bind to icos. These antibodies can be used in methods to treat, for example, cancer.

MA41826A 2015-03-23 2016-03-22 Anti-icos antibodies MA41826B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562137034P 2015-03-23 2015-03-23
PCT/US2016/023524 WO2016154177A2 (en) 2015-03-23 2016-03-22 Antibodies to icos

Publications (1)

Publication Number Publication Date
MA41826B1 true MA41826B1 (en) 2020-08-31

Family

ID=59256490

Family Applications (1)

Application Number Title Priority Date Filing Date
MA41826A MA41826B1 (en) 2015-03-23 2016-03-22 Anti-icos antibodies

Country Status (2)

Country Link
AR (1) AR104041A1 (en)
MA (1) MA41826B1 (en)

Also Published As

Publication number Publication date
AR104041A1 (en) 2017-06-21

Similar Documents

Publication Publication Date Title
MA46708B1 (en) Anti-pd1 antibodies and their uses
MY191169A (en) Anti-fcrh5 antibodies
EA201990615A1 (en) Pyrrolobenzodiazepine conjugates
MA39313A1 (en) Anti-egfrviii antibodies and their uses in the treatment of various cancers
MA40576B1 (en) Anti-her2 antibodies and immunoconjugates
CL2018003758A1 (en) Anti-dll3-antibody antibody conjugates and methods of use. (divisional application 201800458)
ZA201906832B (en) Novel psma-binding agents and uses thereof
MA39095A1 (en) Anti-cd33 antibodies and immunoconjugates
MA43018B1 (en) Anti-pd1 antibodies and methods of use
WO2017132580A3 (en) Split inteins with exceptional splicing activity
MA43187B1 (en) Subcutaneous anti-cd38 antibody formulations and their uses
TR201901445T4 (en) Il2rbeta / common gamma chain antibodies.
EP4335874A3 (en) Anti-hla-g antibodies and use thereof
MX2017016169A (en) Anti-her2 antibodies and methods of use.
EA201792616A1 (en) MEANS, METHODS OF APPLICATION AND METHODS OF TREATMENT FOR SYNUCLEOPATHY
EA202090296A1 (en) SPIROCYCLIC COMPOUNDS AND METHODS FOR THEIR PREPARATION AND APPLICATION
MA39172A1 (en) Heterocyclic bicyclic derivatives as bromodomaine inhibitors
EA202190609A1 (en) ANTIBODIES AGAINST HLA-G, COMPOSITIONS CONTAINING ANTIBODIES AGAINST HLA-G, AND METHODS OF APPLICATION ANTIBODIES AGAINST HLA-G
WO2017136659A3 (en) Humanized anti-cd3 antibodies, conjugates and uses thereof
PH12019501872A1 (en) Anti-tryptase antibodies, compositions thereof, and uses thereof
MA47221A1 (en) Monoclonal antibody to pd-l1
EA201591665A1 (en) ORAL STRUCTURES DEFERASYROX
CL2018000092A1 (en) Antibodies that bind to spellin and inhibit the union of progranulin.
EA201891299A1 (en) THERAPEUTIC ANTIBODIES TO CD9
PH12020550964A1 (en) Heavy chain antibodies binding to cd22